NASDAQ:BNR Burning Rock Biotech Q1 2026 Earnings Results & Report $13.07 +0.57 (+4.56%) Closing price 04:00 PM EasternExtended Trading$13.30 +0.23 (+1.78%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Burning Rock Biotech beat analyst earnings expectations but missed on revenue in its Q1 2026 results, released June 9, 2026. The company reported EPS of -$0.20 versus the -$2.2884 consensus estimate, while revenue of $15.66 million fell short of the $19.21 million estimate by $3.55 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2026Report DateJune 9, 2026TimeBefore Market OpensConference Call6:00 AM ET Burning Rock Biotech EPS ResultsActual EPS-$0.20Consensus EPS -$2.2884Beat/MissBeat by +$2.0884One Year Ago EPSN/ABurning Rock Biotech Revenue ResultsActual Revenue$15.66 millionExpected Revenue$19.21 millionBeat/MissMissed by -$3.55 millionYoY Revenue GrowthN/AConference Call ResourcesSlide DeckPress Release (6-K)Earnings HistoryCompany ProfileSlide DeckFull Screen Slide DeckPowered by Earnings DocumentsPress Release(6-K) Burning Rock Biotech Q1 2026 Earnings FAQ Did Burning Rock Biotech beat earnings estimates for Q1 2026? Burning Rock Biotech (NASDAQ:BNR) reported earnings of -$0.20 per share for Q1 2026, beating the consensus estimate of -$2.2884. The report was announced on Tuesday, June 9, 2026. What was Burning Rock Biotech's revenue for Q1 2026? Burning Rock Biotech reported revenue of $15.66 million for Q1 2026, against a consensus estimate of $19.21 million. Burning Rock Biotech Earnings HeadlinesBurning Rock Announces 2026 Annual General Meeting to be Held on December 22, 2026November 17 at 4:56 AM | globenewswire.comBurning Rock Biotech (BNR) versus Its Competitors Critical AnalysisNovember 17 at 2:12 AM | americanbankingnews.comFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leading Weiss Ratings, the only conflict-free rating agency in the US. Now he says a $3 trillion problem could trigger a chain reaction of crashes and failures, causing a global freeze in financial markets.November 18 at 1:00 AM | Weiss Ratings (Ad)Burning Rock Biotech (BNR) Projected to Release Earnings on TuesdayNovember 16 at 1:40 AM | americanbankingnews.comBurning Rock Biotech Ltd (BNR) Shares Surge 3.3% -- What GF Score of 53 Tells InvestorsSeptember 25, 2026 | gurufocus.comBurning Rock Q2 Revenue Falls 9%; In-Hospital Business Posts GrowthSeptember 10, 2026 | rttnews.comSee More Burning Rock Biotech Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Burning Rock Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Burning Rock Biotech and other key companies, straight to your email. Email Address About Burning Rock BiotechBurning Rock Biotech (NASDAQ:BNR) is a precision oncology company that develops and provides next-generation sequencing tests for cancer. Its testing uses tissue and blood samples to help inform treatment decisions, monitor disease and support cancer research. The company also provides research and clinical-trial services to pharmaceutical companies, including support for the development of cancer therapies and diagnostic tests. Burning Rock is headquartered in Guangzhou, China, and its business primarily serves the Chinese healthcare and life sciences markets. Founded in 2014, Burning Rock focuses on applying genomic testing to cancer care, including the development of tests for treatment selection and disease monitoring.View Burning Rock Biotech ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes ShapeGeneral Motors Faces a Cost Squeeze as Factory Automation Takes Center StageNVIDIA's Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?5 Consumer Discretionary Plays Showing Strength During the Tech Sell-OffAMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?Viking’s Low-Water Miss Looks Like a Buy-the-Dip OpportunityDisney Has the Magic Touch: Dividend Growth and Buybacks Could Fuel a Breakout Upcoming Earnings NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026)Ross Stores (11/19/2026)Walmart (11/19/2026)Intuit (11/19/2026)Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.